Cel-Sci
CVM
#9847
Rank
NZ$75.64 M
Marketcap
NZ$9.00
Share price
1.94%
Change (1 day)
-56.31%
Change (1 year)

Cel-Sci (CVM) - Cash on Hand

Cash on Hand as of September 2025 : NZ$18.76 Million

According to Cel-Sci 's latest financial reports the company has NZ$18.76 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cel-Sci - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-09-30NZ$18.89 M153.08%
2024-09-30NZ$7.46 M7.98%
2023-09-30NZ$6.91 M-82.81%
2022-09-30NZ$40.22 M-34.28%
2021-09-30NZ$61.2 M161.36%
2020-09-30NZ$23.41 M73.65%
2019-09-30NZ$13.48 M-13.37%
2018-09-30NZ$15.56 M372.44%
2017-09-30NZ$3.29 M-18.03%
2016-09-30NZ$4.01 M-55.16%
2015-09-30NZ$8.96 M-17.79%
2014-09-30NZ$10.9 M21634.11%
2013-09-30NZ$0.05 M-98.95%
2012-09-30NZ$4.76 M-14.24%
2011-09-30NZ$5.55 M-84.67%
2010-09-30NZ$36.2 M-23.02%
2009-09-30NZ$47.03 M3376.02%
2008-09-30NZ$1.35 M-90.57%
2007-09-30NZ$14.34 M15.86%
2006-09-30NZ$12.37 M336.83%
2005-09-30NZ$2.83 M-55.34%
2004-09-30NZ$6.34 M114.07%
2003-09-30NZ$2.96 M-32.87%
2002-09-30NZ$4.41 M-24.42%
2001-09-30NZ$5.84 M-77.75%
2000-09-30NZ$26.26 M130.41%
1999-09-30NZ$11.39 M-54.4%
1998-09-30NZ$25 M357%
1997-09-30NZ$5.47 M9.25%
1996-09-30NZ$5 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Curis
CRIS
NZ$15.5 M-17.37%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$0.36 B 1,843.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$16.18 B 86,128.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$0.80 B 4,200.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.77 B 20,012.29%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
NZ$31.80 B 169,361.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.42 B 2,141.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ$5.22 M-72.18%๐Ÿ‡บ๐Ÿ‡ธ USA